GENERINI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.821
EU - Europa 2.403
AS - Asia 1.226
SA - Sud America 192
OC - Oceania 39
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.791
RU - Federazione Russa 986
PL - Polonia 420
SG - Singapore 376
CN - Cina 269
HK - Hong Kong 252
IE - Irlanda 230
SE - Svezia 216
BR - Brasile 163
IT - Italia 146
KR - Corea 125
DE - Germania 114
UA - Ucraina 83
FI - Finlandia 72
GB - Regno Unito 53
VN - Vietnam 53
TR - Turchia 41
AU - Australia 38
IN - India 33
FR - Francia 24
CA - Canada 22
CH - Svizzera 19
JO - Giordania 19
AR - Argentina 12
AT - Austria 11
JP - Giappone 11
IQ - Iraq 10
ID - Indonesia 9
BD - Bangladesh 8
ZA - Sudafrica 8
CI - Costa d'Avorio 7
BJ - Benin 6
EC - Ecuador 6
ES - Italia 5
MX - Messico 5
AL - Albania 4
MA - Marocco 3
NL - Olanda 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
SC - Seychelles 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CO - Colombia 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
VE - Venezuela 2
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GI - Gibilterra 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SN - Senegal 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.718
Salva come PNG Salva come JPEG
Città #
Santa Clara 995
Warsaw 420
Fairfield 344
Ashburn 326
Chandler 295
Dublin 230
Singapore 223
Hong Kong 201
Woodbridge 144
Jacksonville 130
Cambridge 129
Seattle 126
Seoul 124
Wilmington 120
Beijing 108
Buffalo 108
Houston 87
Los Angeles 61
Princeton 61
Medford 48
Boardman 44
Munich 44
Ann Arbor 41
Altamura 40
Izmir 37
Melbourne 37
Lawrence 35
Hefei 33
Boston 32
Moscow 32
New York 26
Shanghai 23
Mumbai 20
Paris 20
Bern 18
Florence 17
San Diego 17
Dallas 15
The Dalles 15
Turku 15
Kent 13
São Paulo 13
Ho Chi Minh City 12
Milan 11
Tokyo 11
Vienna 11
Yubileyny 11
Hanoi 10
Dong Ket 8
West Jordan 8
Abidjan 7
Toronto 7
Cotonou 6
Montreal 6
Norwalk 6
Poplar 6
Brooklyn 5
Chicago 5
Guangzhou 5
Jakarta 5
Salerno 5
Andover 4
Baghdad 4
Biên Hòa 4
Brasília 4
Charlotte 4
Clifton 4
Curitiba 4
Frankfurt am Main 4
Greenwich 4
Guarulhos 4
Hillsboro 4
Johannesburg 4
Manchester 4
Phoenix 4
Rio de Janeiro 4
Salvador 4
Ankara 3
Auburn Hills 3
Belo Horizonte 3
Erbil 3
Falkenstein 3
Falls Church 3
Frankfurt Am Main 3
Giessen 3
Guayaquil 3
Hangzhou 3
Indianapolis 3
London 3
Mexico City 3
Newark 3
Parma 3
Porto Alegre 3
Pune 3
Redondo Beach 3
Rome 3
San Mateo 3
Addis Ababa 2
Ahmedabad 2
Almaty 2
Totale 5.142
Salva come PNG Salva come JPEG
Nome #
[Peripheral nervous system in limited systemic sclerosis]. 304
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 301
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 291
DRESS syndrome in a patient with chronic hepatic encephalopathy. 182
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 181
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 179
Estrogens and neuropeptides in Raynaud's phenomenon. 171
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 169
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. 167
Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. 166
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 163
Oxidative stress in Systemic Sclerosis. 160
Screening of distress among hospitalized patients in a department of internal medicine. 159
Longitudinal ultrasound and clinical follow-up of Baker's cysts injection with steroids in knee osteoarthritis. 156
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 149
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 143
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 142
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 141
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 137
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 137
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 135
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. 134
Current Treatment Options in Raynaud's Phenomenon. 134
Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. 133
Somatostatin-induced modulation of inflammation in experimental arthritis 132
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 132
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 131
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 130
NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. 129
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 128
Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. 127
A Sonographic (Us) Evaluation Of Ligaments Of Sacroiliac Joint In Healthy Subjects 127
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 125
Evidence for the prevention of enthesitis in HLA-B27/hβ(2) m transgenic rats treated with a monoclonal antibody against TNF-α 119
NEPRILYSIN LEVELS IN PLASMA AND SYNOVIAL FLUID OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS. RHEUMATOL INT. 2005 JUN;25(5):336-40. EPUB 2004 MAR 3. 118
Evidence of immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis. 118
Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. 117
Postural and kinesiologic evaluation in patients with early ankylosing spondylitis. 115
Evidence for hyaluronan production in the air pouch model in rats. 114
The loss of endothelium dependent vascular tone control in systemic sclerosis. 113
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review. 111
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. 104
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). 104
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. 102
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 100
Raynaud's phenomenon and vascular disease in systemic sclerosis. 98
Neuropeptides and steroid hormones in arthritis. 97
Vasculitides secondary to systemic diseases. 95
TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats 91
The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. 86
Therapy of spondylarthropathy in inflammatory bowel disease. 79
Systemic sclerosis. A clinical overview. 78
Erratum: "The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn) (Clinical and Experimental Rheumatol (2005) vol. 23 (5) (671-677)) 77
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. 75
Raynaud's phenomenon and systemic sclerosis. 69
Iliopsoas bursitis in rheumatoid arthritis. 68
New approaches to Raynaud's phenomenon [corrected]. 67
Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels. 67
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. 64
Totale 7.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021298 0 0 0 0 0 66 13 41 41 65 29 43
2021/2022354 10 37 10 11 8 15 13 15 15 13 92 115
2022/20231.019 105 153 39 102 86 188 124 53 96 15 32 26
2023/2024387 14 39 63 18 34 67 15 85 2 16 25 9
2024/20252.641 80 263 189 427 866 340 30 99 137 54 99 57
2025/20261.318 343 349 184 139 274 29 0 0 0 0 0 0
Totale 7.741